How to Buy Wave Life Sciences Stock

Wave Life Sciences Ltd

Wave Life Sciences Ltd. , a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform.

Wave Life Sciences stock last closed at $7.10, up 0.14% from the previous day, and has increased 22.41% in one year. It has overperformed other stocks in the Biotechnology industry by 0.41 percentage points. Wave Life Sciences stock is currently +41.43% from its 52-week low of $5.02, and -67.33% from its 52-week high of $21.73.

At the moment, there are 188.25M shares of WVE outstanding. The market capitalization of WVE is $1.34B. In the last 24 hours, 2.67M WVE shares were traded.

How to Buy Wave Life Sciences Stock

Not sure how to invest in Wave Life Sciences stock? Here's how.

  1. Choose where to buy Wave Life Sciences stock: You need to choose an online brokerage, but don't worry - we've tested dozens of online stock brokerages and apps to help you decide where to buy Wave Life Sciences stock.
  2. Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Fund your brokerage account: Select your method of payment and add your details.
  4. Research Wave Life Sciences stock: The Wave Life Sciences ticker symbol is WVE. Is Wave Life Sciences stock a good investment? Should you buy shares of WVE? How do WVE's underlying business fundamentals look? Do top analysts think Wave Life Sciences is a good buy? Why has WVE's stock price moved recently? (Hint: Our stock research website can help you evaluate if WVE is a good stock to buy).
  5. Place your WVE trade: Decide if you will purchase WVE shares at the current market price or use a limit order to buy WVE shares at a particular price.
  6. Keep an eye on your investment in WVE: Create a watchlist to get the latest news on your new investment in Wave Life Sciences stock.

Step 1: Choose where to buy Wave Life Sciences stock

You need an online brokerage account to access the NASDAQ market and buy WVE shares.

A brokerage account allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

In our opinion, eToro is the best online stock brokerage. eToro gives you:

  • You can invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global financial markets: From Tech to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
  • Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Create a brokerage account

Now that you've chosen your brokerage, you need to fill out some personal information so you are able to invest in WVE today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to create a new brokerage account.
  1. Submit your application by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Fund your brokerage account

Now that you have opened your account on the best stock app, your next step is to transfer the money for your investment:

Watch the video below for more details transferring money into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Wave Life Sciences stock

After you have identified the best place to buy Wave Life Sciences stock, it's absolutely critical to analyze their stock prior to investing, so you truly understand the risk and upside.

Wave Life Sciences quick stats

WVE Price
$7.10
1w %
-2.07%
1y %
22.41%
5y %
13.42%
P/E
-5.87x
P/B
2.58x
P/S
28.06x
PEG
N/A
Revenue
$42.73M
Earnings
-$204.38M
Fore. Rev. Growth
54.95%
Fore. Earn. Growth
N/A
Market Cap
$1.34B
Next Earnings
May 7, 2026
Next Dividend
N/A

WVE Due Diligence Score

WallStreetZen was built to help part-time investors do more accurate fundamental analysis in less time.

You can see all of the due diligence checks on WVE's stock page.

Is WVE stock properly valued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge WVE's fair value.

Using relative valuations methods:

  • WVE could be undervalued based on its P/B ratio of 2.58x, relative to Biotechnology industry P/B ratio of 4.75x

You can access more valuation analysis on WVE's stock here.

WVE Financial Health

Positive Financial Indicators:

  • WVE has cash burn of 188211000. It has sufficient cash and short-term investments to cover this for at least one year.
  • There are more short-term assets than long-term liabilities on the WVE balance sheet.
  • Total WVE debt is lower than 5 years ago, relative to shareholder equity.
  • WVE has $602.07M in cash and short term investments. This is enough to cover its annual cash burn of $188.21M.
  • WVE has a low debt to equity ratio of 0.22.
  • There are more short-term assets than short-term liabilities on the WVE balance sheet.

Negative Financial Indicators:

  • WVE profit margin has gone down from -89.6% to -478.3% in the past year.

Is it a good time to buy Wave Life Sciences stock, according to Wall Street analysts?

Out of 13 Equities analysts who give forecasts on WVE, the consensus analyst rating on Wave Life Sciences is a Strong Buy

It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.

Latest WVE Analyst Upgrades/Downgrades

Andrew S. Fein, a top 14% analyst from HC Wainwright & Co. reiterates WVE with a buy rating and maintains their WVE price target from $30.00 to $30.00, on Mar 2, 2026.

Steve Seedhouse, a top 26% analyst from Cantor Fitzgerald maintains WVE with a strong buy rating and raises their WVE price target from $34.00 to $41.00, on Feb 5, 2026.

Cheng Li, a bottom 19% analyst from Oppenheimer maintains WVE with a buy rating and raises their WVE price target from $24.00 to $32.00, on Dec 16, 2025.

Joon Lee, a top 2% analyst from Truist Securities maintains WVE with a strong buy rating and raises their WVE price target from $36.00 to $50.00, on Dec 15, 2025.

Truist Securities's Joon Lee raised their price target on Wave Life Sciences (NASDAQ: WVE) by 38.9% from $36 to $50 on 2025/12/15. The analyst maintained their Strong Buy rating on the stock.

Lee contextualized their price target by pointing out that Truist Securities' obesity model for WVE-007 is a "conservative placeholder" because it tracks maturing data that may fundamentally shift the conversation from "weight loss" to "quality weight loss" that, if successfully developed, could drive greater utilization of WVE-007 at a higher premium.

Their firm expects competition for WVE-007, the analyst noted, but also sees Wave Life Sciences' stereopure siRNA platform with innovative backbone chemistry as offering a wide moat that four consecutive successful data readouts have now validated.

Madison El-Saadi, a top 27% analyst from B. Riley Securities maintains WVE with a strong buy rating and raises their WVE price target from $19.00 to $37.00, on Dec 12, 2025.

You can dig deeper into what analysts are saying on the Wave Life Sciences stock forecast page.

WVE Trading Indicators

SMA10
7.87
SMA20
10.26
SMA50
12.15
SMA100
12.5
SMA200
10.19
MACD
-1.74
MACD Signal
-1.41
MACD Histogram
-0.32
RSI
29.54
Stochastic %K
27.09
Stochastic %D
25.45
StochRSI %K
41.76
StochRSI %D
37.65

WVE Performance Numbers

Last year, WVE revenue was $42.73M. During the last five year, WVE's revenue has increased by 16.31% per year. This was slower than the Biotechnology industry average of 28%.

Dive into WVE's earnings and revenue performance here.

Who is buying/selling WVE?

Over the past year, executives and large shareholders at WVE have bought more shares than they have sold.

Ra Capital Management LP, Director of WVE, was the latest WVE insider to buy. They bought $6,312,091.50 worth of WVE shares on Mar 30, 2026.

Learn more about who owns WVE stock here.

Does WVE stock generate passive income?

No, Wave Life Sciences doesn't provide an income stream by paying out dividends.

Get opinions from other traders

One of the biggest reasons eToro is our favorite brokerage is because of its social trading community.

Click below to find out what other community members have to say.

Step 5: Place your WVE trade

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are generally fine for most investors.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to be sure you're buying or selling at an exact price, place a limit order.

Press the Open button and your broker will place your order.

If you want additional help buying stocks on eToro, click the how to video below:

Open eToro Account

Step 6: Keep an eye on your investment in WVE

Now that you own some WVE stock, you'll want to keep up with your new investment.

Make a watchlist to keep tabs on your WVE stock.

WVE Feed

How to Buy Stock in Wave Life Sciences

To reiterate, here are the 6 steps for buying Wave Life Sciences stock:

  1. Choose where to buy Wave Life Sciences stock
  2. Create a brokerage account
  3. Fund your brokerage account
  4. Research Wave Life Sciences stock
  5. Place your WVE trade
  6. Keep an eye on your investment in WVE

If you require a brokerage account, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep an eye on your new investment in Wave Life Sciences, get started below.

NASDAQ: WVE
$7.10+0.01 (+0.14%)
Updated Apr 7, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: WVE
$7.10+0.01 (+0.14%)
Updated Apr 7, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Wave Life Sciences share?

As of Apr 7, 2026, it costs $7.10 to buy one share of Wave Life Sciences stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $3, you can buy 0.423 shares of WVE.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Wave Life Sciences stock?

According to 13 Wall Street analysts who monitor Wave Life Sciences, their consensus recommendation is to buy Wave Life Sciences stock.

What is the best way to buy Wave Life Sciences stock?

One way to place an order for Wave Life Sciences stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.